Trial Title:
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment, MODERN Study
NCT ID:
NCT05987241
Condition:
Muscle Invasive Bladder Urothelial Carcinoma
Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
Stage IV Bladder Urothelial Carcinoma AJCC v7
Conditions: Official terms:
Carcinoma
Carcinoma, Transitional Cell
Nivolumab
Relatlimab
Immunoglobulins
Immunoglobulin G
Study type:
Interventional
Study phase:
Phase 2/Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Biospecimen Collection
Description:
Undergo collection of tissue and blood
Arm group label:
Cohort A, Arm I (nivolumab)
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Arm group label:
Cohort B, Arm III (nivolumab)
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Other name:
Biological Sample Collection
Other name:
Biospecimen Collected
Other name:
Specimen Collection
Intervention type:
Other
Intervention name:
cfDNA or ctDNA Measurement
Description:
Undergo ctDNA surveillance
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Other name:
Cell-Free DNA/Circulating Tumor DNA Measurement
Other name:
cfDNA/ctdDNA Measurement
Other name:
cfDNA/ctDNA
Other name:
cfDNA/ctDNA Measurement
Other name:
Circulating Cell-Free DNA/Circulating Tumor-Derived DNA Measurement
Intervention type:
Procedure
Intervention name:
Computed Tomography
Description:
Undergo CT
Arm group label:
Cohort A, Arm I (nivolumab)
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Arm group label:
Cohort B, Arm III (nivolumab)
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Other name:
CAT
Other name:
CAT Scan
Other name:
Computed Axial Tomography
Other name:
Computerized Axial Tomography
Other name:
Computerized axial tomography (procedure)
Other name:
Computerized Tomography
Other name:
Computerized Tomography (CT) scan
Other name:
CT
Other name:
CT Scan
Other name:
tomography
Intervention type:
Procedure
Intervention name:
Magnetic Resonance Imaging
Description:
Undergo MRI
Arm group label:
Cohort A, Arm I (nivolumab)
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Arm group label:
Cohort B, Arm III (nivolumab)
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Other name:
Magnetic Resonance
Other name:
Magnetic Resonance Imaging (MRI)
Other name:
Magnetic resonance imaging (procedure)
Other name:
Magnetic Resonance Imaging Scan
Other name:
Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
Other name:
MR
Other name:
MR Imaging
Other name:
MRI
Other name:
MRI Scan
Other name:
MRIs
Other name:
NMR Imaging
Other name:
NMRI
Other name:
Nuclear Magnetic Resonance Imaging
Other name:
sMRI
Other name:
Structural MRI
Intervention type:
Biological
Intervention name:
Nivolumab
Description:
Given IV
Arm group label:
Cohort A, Arm I (nivolumab)
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Arm group label:
Cohort B, Arm III (nivolumab)
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Other name:
ABP 206
Other name:
BCD-263
Other name:
BMS 936558
Other name:
BMS-936558
Other name:
BMS936558
Other name:
CMAB819
Other name:
MDX 1106
Other name:
MDX-1106
Other name:
MDX1106
Other name:
NIVO
Other name:
Nivolumab Biosimilar ABP 206
Other name:
Nivolumab Biosimilar BCD-263
Other name:
Nivolumab Biosimilar CMAB819
Other name:
ONO 4538
Other name:
ONO-4538
Other name:
ONO4538
Other name:
Opdivo
Intervention type:
Other
Intervention name:
Quality-of-Life Assessment
Description:
Ancillary studies
Arm group label:
Cohort A, Arm I (nivolumab)
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Arm group label:
Cohort B, Arm III (nivolumab)
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Other name:
Quality of Life Assessment
Intervention type:
Other
Intervention name:
Questionnaire Administration
Description:
Ancillary studies
Arm group label:
Cohort A, Arm I (nivolumab)
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Arm group label:
Cohort B, Arm III (nivolumab)
Arm group label:
Cohort B, Arm IV (ctDNA surveillance, nivolumab)
Intervention type:
Biological
Intervention name:
Relatlimab
Description:
Given IV
Arm group label:
Cohort A, Arm II (nivolumab, relatlimab)
Other name:
BMS 986016
Other name:
BMS-986016
Other name:
BMS986016
Other name:
Immunoglobulin G4, Anti-(human Lymphocyte Activation Gene-3 Protein) (Human Heavy Chain), Disulfide with Human Light Chain, Dimer
Summary:
This phase II/III trial examines whether patients who have undergone surgical removal of
bladder, but require an additional treatment called immunotherapy to help prevent their
bladder cancer from coming back, can be identified by a blood test. Many types of tumors
tend to lose cells or release different types of cellular products including their DNA
which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes
can be seen on scans. Health care providers can measure the level of ctDNA in blood or
other bodily fluids to determine which patients are at higher risk for disease
progression or relapse. In this study, a blood test is used to measure ctDNA and see if
there is still cancer somewhere in the body after surgery and if giving a treatment will
help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab
and relatlimab, can help the body's immune system to attack the cancer, and can interfere
with the ability of tumor cells to grow and spread. This trial may help doctors determine
if ctDNA measurement in blood can better identify patients that need additional
treatment, if treatment with nivolumab prolongs patients' life and whether the additional
immunotherapy treatment with relatlimab extends time without disease progression or
prolongs life of bladder cancer patients who have undergone surgical removal of their
bladder.
Detailed description:
PRIMARY OBJECTIVES:
I. To compare the ctDNA clearance proportion (i.e., ctDNA positive [+] --> ctDNA negative
[-]) at 12 weeks in patients enrolled in Cohort A treated with adjuvant nivolumab versus
nivolumab + relatlimab (phase 2 portion).
II. To compare overall survival in patients enrolled in Cohort A treated with adjuvant
nivolumab versus nivolumab + relatlimab (phase 3 portion).
III. To compare disease-free survival in patients enrolled in Cohort B randomized to
immediate treatment with nivolumab to those randomized to surveillance with subsequent
treatment with nivolumab only upon converting to ctDNA(+)
SECONDARY OBJECTIVES:
I. To compare disease-free survival in patients enrolled in Cohort A treated with
adjuvant nivolumab versus nivolumab + relatlimab.
II. To define the association between ctDNA clearance and disease-free survival and
overall survival for Cohort A patients.
III. To compare overall survival in patients enrolled in Cohort B randomized to immediate
treatment with nivolumab to those randomized to surveillance with subsequent treatment
with nivolumab only upon converting to ctDNA(+).
IV. To determine the lead time from a ctDNA(+) assay to radiographic recurrence in
patients initially ctDNA(-) post-definitive surgery enrolled in Cohort B.
V. To estimate the proportion of Cohort B patients on Arm 4 who become ctDNA(+) and
receive nivolumab.
VI. To compare the cumulative incidence of Cohort B patients who become ctDNA(+) between
Arms 3 and 4.
VII. To determine the safety of adjuvant nivolumab plus relatlimab.
EXPLORATORY OBJECTIVES:
I. To explore the kinetics of quantitative ctDNA levels (mean number of tumor molecules
observed per mL of plasma or MTM/ml) over time and the association between ctDNA kinetics
and time-to-event outcomes.
II. To estimate the costs and value of care in patients with a ctDNA(+) assay
post-cystectomy treated with adjuvant nivolumab versus nivolumab + relatlimab.
III. To estimate the costs and value of care in patients with a ctDNA(-) assay
post-cystectomy treated with adjuvant nivolumab versus surveillance with subsequent
treatment with nivolumab at the time of conversion to ctDNA(+).
QUALITY OF LIFE OBJECTIVES:
I. Within each cohort, to compare quality-adjusted survival among randomized arms using
European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L).
II. Within Cohort B, to compare overall quality of life (QOL) as measured by the European
Organization for the Research and Treatment of Cancer (EORTC) Quality of Life
Questionnaire-Core 30 (QLQ-C30) between baseline and 42 months (calculated as the area
under the curve) among randomized arms.
III. Within each cohort, to compare overall QOL as measured by the EORTC QLQ-C30 at each
time point among randomized arms.
IV. Within each cohort, to compare bladder cancer-specific QOL as measured by the EORTC
Bladder Cancer Muscle-Invasive 30 Questionnaire (QLQ-BLM30) at each time point among
randomized arms.
V. Within each cohort, to compare patient-reported fatigue as measured by Patient
Reported Outcomes Measurement Information System (PROMIS)-Fatigue at each time point
among randomized arms.
OUTLINE: Patients are assigned to 1 of 2 cohorts based on ctDNA results.
COHORT A: Patients who are ctDNA(+) are randomized to 1 of 2 arms:
ARM I: Patients receive nivolumab intravenously (IV) over 30 minutes on day 1 of each
cycle. Treatment repeats every 28 days for up to 12 cycles in the absence of disease
progression or unacceptable toxicity. Patients also undergo collection of tissue during
screening and collection of blood throughout the trial. Patients also undergo computed
tomography (CT) or magnetic resonance imaging (MRI) scans throughout the trial.
ARM II: Patients receive nivolumab IV over 30 minutes and relatlimab IV over 30 minutes
on day 1 of each cycle. Treatment repeats every 28 days for up to 12 cycles in the
absence of disease progression or unacceptable toxicity. Patients also undergo collection
of tissue during screening and collection of blood throughout the trial. Patients also
undergo CT or MRI scans throughout the trial.
COHORT B: Patients who are ctDNA(-) are randomized to 1 of 2 arms:
ARM III: Patients receive nivolumab IV over 30 minutes on day 1 of each cycle. Treatment
repeats every 28 days for up to 12 cycles in the absence of disease progression or
unacceptable toxicity. Patients also undergo collection of tissue during screening and
collection of blood throughout the trial. Patients also undergo CT or MRI scans
throughout the trial.
ARM IV: Patients undergo ctDNA surveillance consisting of collection of tissue and blood
during screening and collection of blood only on study and during follow up. Patients who
convert to ctDNA(+) during surveillance then receive nivolumab IV over 30 minutes and
relatlimab IV over 30 minutes on day 1 of each cycle. Treatment repeats every 28 days for
up to 12 cycles in the absence of disease progression or unacceptable toxicity. Patients
also undergo CT or MRI scans throughout the trial.
After completion of study treatment, patients are followed up at weeks 60, 72, 84, 96,
120, 144, 196, and 248.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- PRE-REGISTRATION: Histologically confirmed muscle-invasive urothelial carcinoma of
the bladder. Variant histology, including neuroendocrine differentiation, is allowed
if urothelial cancer is predominant histology (any amount of squamous
differentiation is allowed provided the tumor is not a pure squamous cell cancer)
- PRE-REGISTRATION: Patient must have had radical cystectomy and lymph node dissection
>= 3 weeks, but =< 12 weeks prior to pre-registration. Patients who have had a
partial cystectomy as definitive therapy are not eligible
- PRE-REGISTRATION: No gross cancer at the surgical margins. Microscopic invasive
urothelial carcinoma at the surgical margins (i.e., "positive margins") are allowed.
Carcinoma in situ (CIS) at margins is considered negative margins
- PRE-REGISTRATION: No evidence of residual cancer or metastasis after cystectomy
(imaging is not required prior to pre-registration but is required prior to
registration)
- PRE-REGISTRATION: Have undergone a radical cystectomy with pathological evidence of
urothelial carcinoma of the bladder at high risk of recurrence as described in one
of the two scenarios below (i or ii). The 7th edition of American Joint Committee on
Cancer (AJCC) staging will be utilized.:
- (i) Patients who have not received neoadjuvant cisplatin-based chemotherapy:
pT3-pT4* or pT0/x-pT4/N+ on cystectomy and are not eligible for adjuvant
cisplatin chemotherapy
- (i) Patients ineligible for cisplatin due to at least one of the following
criteria and reason for ineligibility should be documented:
- (i) Creatinine Clearance (using Cockcroft-Gault): < 60 mL/min
- (i) Common Terminology Criteria for Adverse Events (CTCAE) version 5,
grade >= 2 audiometric hearing loss
- (i) CTCAE version 5, grade >= 2 or above peripheral neuropathy
- New York Heart Association Class III heart failure
- (i) Eastern Cooperative Oncology Group (ECOG) performance status = 2
- (i) Patients who are eligible for cisplatin may be candidates if they
refuse available adjuvant chemotherapy, despite being informed by the
investigator about the treatment options. The patient's refusal must be
documented.
- (i) Patients with pT2N0 urothelial cancer on cystectomy (without
prior neoadjuvant chemotherapy) with ctDNA(+) Signatera results based
on an assay performed post-cystectomy as part of routine care outside
of the study may proceed with pre-registration but require
confirmation of ctDNA(+) Signatera testing on repeat "central
testing" in the context of A032103 testing. Patients with pT2N0 with
central testing not confirming ctDNA(+) will not be eligible for
A032103 (Note: this is distinct from patients with ypT2N0 who are
eligible based on ii).
- (ii) Patients who received cisplatin-based neoadjuvant chemotherapy: ypT2-ypT4
or ypT0/x-pT4/N+ on cystectomy
- PRE-REGISTRATION: Available tumor tissue for central Signatera testing to be
submitted after pre-registration. Central testing is defined as testing performed as
part of the A032103 study prior to registration and is provided by the study and not
routine standard commercial testing. Patients who have already had Signatera testing
performed as part of routine care will require repeat central testing as part of the
A032103 study to be eligible for registration/randomization. Tumor tissue from the
cystectomy is preferred over tissue from prior transurethral resection
- PRE-REGISTRATION: Age >= 18 years
- PRE-REGISTRATION: ECOG Performance Status 0-2
- PRE-REGISTRATION: Not pregnant and not nursing, because this study involves an agent
that has known genotoxic, mutagenic and teratogenic effects
- PRE-REGISTRATION: No postoperative/adjuvant systemic therapy after cystectomy
- PRE-REGISTRATION: No adjuvant radiation after cystectomy
- PRE-REGISTRATION: No treatment with any other type of investigational agent =< 4
weeks before pre-registration
- PRE-REGISTRATION: Not have ever received prior treatment with PD-1/PD-L1 blockade.
- PRE-REGISTRATION: Not have ever received prior treatment with LAG-3 blockade.
- PRE-REGISTRATION: Patients with a prior or concurrent malignancy whose natural
history or treatment does not have the potential to interfere with the safety or
efficacy assessment of the investigational regimen are eligible for this trial
- PRE-REGISTRATION: Absolute Neutrophil Count (ANC) >= 1,200/mm^3
- PRE-REGISTRATION: Platelet count >= 100,000/mm^3
- PRE-REGISTRATION: Hemoglobin >= 8 g/dL
- PRE-REGISTRATION: Creatinine =< 1.5 x upper limit of normal (ULN) or calculated
(calc.) creatinine clearance > 30 mL/min (using either Cockcroft-Gault formula or
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
- PRE-REGISTRATION: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =<
3 x ULN
- PRE-REGISTRATION: Total bilirubin =< 1.5 x upper limit of normal (ULN) (except in
patients with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL)
- PRE-REGISTRATION: For women of childbearing potential only: A negative urine or
serum pregnancy test done =< 14 days prior to pre-registration is required
- PRE-REGISTRATION: Not currently requiring hemodialysis
- PRE-REGISTRATION: No current or prior history of myocarditis
- PRE-REGISTRATION: No active autoimmune disease or history of autoimmune disease that
might recur, which may affect vital organ function or require immune suppressive
treatment including systemic corticosteroids. These include but are not limited to
patients with a history of immune related neurologic disease, multiple sclerosis,
autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis;
systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective
tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative
colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN),
Stevens- Johnson syndrome, or phospholipid syndrome because of the risk of
recurrence or exacerbation of disease.
- PRE-REGISTRATION: Patients with vitiligo, endocrine deficiencies including type I
diabetes mellitus, thyroiditis managed with replacement hormones including
physiologic corticosteroids are eligible.
- PRE-REGISTRATION: Patients with rheumatoid arthritis and other arthropathies,
Sjögren's syndrome and psoriasis controlled with topical medication and patients
with positive serology, such as antinuclear antibodies (ANA), anti-thyroid
antibodies should be evaluated for the presence of target organ involvement and
potential need for systemic treatment but should otherwise be eligible.
- PRE-REGISTRATION: No current pneumonitis or prior history of non-infectious
pneumonitis that required steroids within the previous 5 years.
- PRE-REGISTRATION: No known active hepatitis B (e.g., hepatitis B surface antigen
[HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid
[RNA] [qualitative] is detected).
- PRE-REGISTRATION: For patients with evidence of chronic hepatitis B virus (HBV)
infection, the HBV viral load must be undetectable on suppressive therapy, if
indicated. Patients with a history of hepatitis C virus (HCV) infection must have
been treated and cured. For patients with HCV infection who are currently on
treatment, they are eligible if they have an undetectable HCV viral load.
- PRE-REGISTRATION: Human immunodeficiency virus (HIV)-infected patients on effective
anti-retroviral therapy with undetectable viral load within 6 months are eligible.
- PRE-REGISTRATION: No concurrent antineoplastic therapy.
- PRE-REGISTRATION: No current immunosuppressive agents (with the exception of
corticosteroids as described below).
- PRE-REGISTRATION: No condition requiring systemic treatment with either
corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive
medications within 14 days of pre-registration (with the exception of steroid
pre-medications for contrast allergies). Inhaled or topical steroids and adrenal
replacement doses < 10 mg daily prednisone equivalents are permitted in the absence
of active autoimmune disease.
- REGISTRATION: Patient must have had radical cystectomy and lymph node dissection =<
18 weeks prior to registration.
- REGISTRATION: Must have evaluable ctDNA Signatera assay result (i.e., ctDNA[+]or
ctDNA[-]) based on test performed as part of central testing after pre-registration
to A032103. Central testing is defined as testing performed as part of the A032103.
Local/commercial testing results may not be used for registration to A032103
- Cisplatin-ineligible (or cisplatin-declining) patients with a pT2N0 urothelial
cancer on cystectomy who were pre-registered based on routine standard care
ctDNA(+) Signatera testing must have confirmed ctDNA(+) Signatera testing on
central testing. If central Signatera testing yields a ctDNA(-) result, these
patients are ineligible. NOTE: This is a distinct consideration from patients
with ypT2-4 and/or ypN+ urothelial cancer (i.e., patients who had received
neoadjuvant cisplatin-based chemotherapy) who are eligible with either ctDNA(+)
or ctDNA(-) central Signatera testing
- REGISTRATION: All patients must have confirmed disease-free status defined as no
measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, or
definitive non-measurable radiographic metastatic disease, within 60 days prior to
registration. Patients with equivocal nodes less than 15 mm in short axis, or < 10
mm in long axis for non-lymph node lesions, not considered by the investigator to
represent malignant disease will be eligible. Attempts should be made to resolve the
etiology of equivocal lesions with complementary imaging (e.g., PET scan) or biopsy.
- REGISTRATION: No major surgery =< 3 weeks before registration.
- REGISTRATION: No live vaccine within 30 days prior to registration. Examples of live
vaccines include, but are not limited to, the following: measles, mumps, rubella,
varicella/zoster (chicken pox), yellow fever, rabies, Bacillus Calmette- Guerin
(BCG), and typhoid vaccine. Seasonal influenza vaccines for injection are generally
killed virus vaccines and are allowed; however, intranasal influenza vaccines (e.g.,
FluMist [registered trademark]) are live attenuated vaccines and are not allowed.
Coronavirus disease 2019 (COVID-19) vaccines are not live vaccines and are allowed
- COHORT B, ARM 4 PATIENTS INITIATING NIVOLUMAB AFTER CONVERSION OF ctDNA ASSAY FROM
ctDNA(-) to ctDNA (+):
- Patient must have converted to ctDNA(+) during serial monitoring performed
centrally in the setting of the A032103 study
- COHORT B, ARM 4 PATIENTS INITIATING NIVOLUMAB AFTER CONVERSION OF ctDNA ASSAY FROM
ctDNA(-) to ctDNA (+):
- No evidence of metastatic disease on the most recent scheduled imaging
assessment as outlined in the study calendar (no repeat imaging is necessary
specifically at the time of the conversion from ctDNA[-] to ctDNA[+]).
- COHORT B, ARM 4 PATIENTS INITIATING NIVOLUMAB AFTER CONVERSION OF ctDNA ASSAY FROM
ctDNA(-) to ctDNA (+):
- No change in clinical condition and/or laboratory tests that would impact the
safety of nivolumab in the opinion of the treating investigator
- COHORT B, ARM 4 PATIENTS INITIATING NIVOLUMAB AFTER CONVERSION OF ctDNA ASSAY FROM
ctDNA(-) to ctDNA (+):
- =< 6 weeks from reporting of ctDNA(+) result by Natera.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Cancer Center at Saint Joseph's
Address:
City:
Phoenix
Zip:
85004
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
720-874-1881
Email:
ResearchInstituteInquiries@CommonSpirit.org
Investigator:
Last name:
Shahzad Siddique
Email:
Principal Investigator
Facility:
Name:
University of Arizona Cancer Center-Orange Grove Campus
Address:
City:
Tucson
Zip:
85704
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
520-694-8900
Investigator:
Last name:
Edward P. Gelmann
Email:
Principal Investigator
Facility:
Name:
Banner University Medical Center - Tucson
Address:
City:
Tucson
Zip:
85719
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
UACC-IIT@uacc.arizona.edu
Investigator:
Last name:
Edward P. Gelmann
Email:
Principal Investigator
Facility:
Name:
University of Arizona Cancer Center-North Campus
Address:
City:
Tucson
Zip:
85719
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
UACC-IIT@uacc.arizona.edu
Investigator:
Last name:
Edward P. Gelmann
Email:
Principal Investigator
Facility:
Name:
Highlands Oncology Group - Fayetteville
Address:
City:
Fayetteville
Zip:
72703
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
479-872-8100
Email:
research@hogonc.com
Investigator:
Last name:
Joseph T. Beck
Email:
Principal Investigator
Facility:
Name:
Highlands Oncology Group - Rogers
Address:
City:
Rogers
Zip:
72758
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
479-872-8130
Email:
research@hogonc.com
Investigator:
Last name:
Joseph T. Beck
Email:
Principal Investigator
Facility:
Name:
Highlands Oncology Group
Address:
City:
Springdale
Zip:
72762
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
479-872-8130
Email:
research@hogonc.com
Investigator:
Last name:
Joseph T. Beck
Email:
Principal Investigator
Facility:
Name:
UC San Diego Moores Cancer Center
Address:
City:
La Jolla
Zip:
92093
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
858-822-5354
Email:
cancercto@ucsd.edu
Investigator:
Last name:
Tyler Stewart
Email:
Principal Investigator
Facility:
Name:
Keck Medicine of USC Koreatown
Address:
City:
Los Angeles
Zip:
90020
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
213-388-0908
Investigator:
Last name:
Sarmad Sadeghi
Email:
Principal Investigator
Facility:
Name:
Los Angeles General Medical Center
Address:
City:
Los Angeles
Zip:
90033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
323-865-0451
Email:
uscnorrisinfo@med.usc.edu
Investigator:
Last name:
Sarmad Sadeghi
Email:
Principal Investigator
Facility:
Name:
USC / Norris Comprehensive Cancer Center
Address:
City:
Los Angeles
Zip:
90033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
323-865-0451
Investigator:
Last name:
Sarmad Sadeghi
Email:
Principal Investigator
Facility:
Name:
USC Norris Oncology/Hematology-Newport Beach
Address:
City:
Newport Beach
Zip:
92663
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
323-865-0451
Investigator:
Last name:
Sarmad Sadeghi
Email:
Principal Investigator
Facility:
Name:
Stanford Cancer Institute Palo Alto
Address:
City:
Palo Alto
Zip:
94304
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
650-498-7061
Email:
ccto-office@stanford.edu
Investigator:
Last name:
Ali R. Khaki
Email:
Principal Investigator
Facility:
Name:
University of California Davis Comprehensive Cancer Center
Address:
City:
Sacramento
Zip:
95817
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
916-734-3089
Investigator:
Last name:
Mamta Parikh
Email:
Principal Investigator
Facility:
Name:
UCHealth University of Colorado Hospital
Address:
City:
Aurora
Zip:
80045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
720-848-0650
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
Poudre Valley Hospital
Address:
City:
Fort Collins
Zip:
80524
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
970-297-6150
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
Cancer Care and Hematology-Fort Collins
Address:
City:
Fort Collins
Zip:
80528
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-9171
Email:
protocols@AllianceNCTN.org
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
UCHealth Greeley Hospital
Address:
City:
Greeley
Zip:
80631
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-9171
Email:
protocols@AllianceNCTN.org
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
UCHealth Highlands Ranch Hospital
Address:
City:
Highlands Ranch
Zip:
80129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
720-848-0650
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
UCHealth Lone Tree Health Center
Address:
City:
Lone Tree
Zip:
80124
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-9171
Email:
protocols@AllianceNCTN.org
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
Medical Center of the Rockies
Address:
City:
Loveland
Zip:
80538
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
970-203-7083
Investigator:
Last name:
Elizabeth R. Kessler
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Derby Care Center
Address:
City:
Derby
Zip:
06418
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center-Fairfield
Address:
City:
Fairfield
Zip:
06824
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Glastonbury
Address:
City:
Glastonbury
Zip:
06033
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Greenwich
Address:
City:
Greenwich
Zip:
06830
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Guilford
Address:
City:
Guilford
Zip:
06437
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Saint Francis
Address:
City:
Hartford
Zip:
06105
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Yale University
Address:
City:
New Haven
Zip:
06520
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Yale-New Haven Hospital North Haven Medical Center
Address:
City:
North Haven
Zip:
06473
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center at Long Ridge
Address:
City:
Stamford
Zip:
06902
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Torrington Care Center
Address:
City:
Torrington
Zip:
06790
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center-Trumbull
Address:
City:
Trumbull
Zip:
06611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital-Waterbury Care Center
Address:
City:
Waterbury
Zip:
06708
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Waterford
Address:
City:
Waterford
Zip:
06385
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Helen F Graham Cancer Center
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Medical Oncology Hematology Consultants PA
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Aventura
Address:
City:
Aventura
Zip:
33180
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
954-461-2180
Investigator:
Last name:
Janaki N. Sharma
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Coral Gables
Address:
City:
Coral Gables
Zip:
33146
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Janaki N. Sharma
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
Address:
City:
Deerfield Beach
Zip:
33442
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Janaki N. Sharma
Email:
Principal Investigator
Facility:
Name:
Malcom Randall Veterans Administration Medical Center
Address:
City:
Gainesville
Zip:
32610
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
352-273-8675
Email:
trials@cancer.ufl.edu
Investigator:
Last name:
Jess DeLaune
Email:
Principal Investigator
Facility:
Name:
University of Florida Health Science Center - Gainesville
Address:
City:
Gainesville
Zip:
32610
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
352-273-8010
Email:
cancer-center@ufl.edu
Investigator:
Last name:
Jonathan A. Chatzkel
Email:
Principal Investigator
Facility:
Name:
University of Miami Miller School of Medicine-Sylvester Cancer Center
Address:
City:
Miami
Zip:
33136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Janaki N. Sharma
Email:
Principal Investigator
Facility:
Name:
Miami Cancer Institute
Address:
City:
Miami
Zip:
33176
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
786-596-2000
Investigator:
Last name:
Rohan Garje
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Kendall
Address:
City:
Miami
Zip:
33176
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Janaki N. Sharma
Email:
Principal Investigator
Facility:
Name:
UM Sylvester Comprehensive Cancer Center at Plantation
Address:
City:
Plantation
Zip:
33324
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
305-243-2647
Investigator:
Last name:
Janaki N. Sharma
Email:
Principal Investigator
Facility:
Name:
Northside Hospital
Address:
City:
Atlanta
Zip:
30342
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
404-303-3355
Email:
ClinicalTrials@northside.com
Investigator:
Last name:
Louis C. Garrot
Email:
Principal Investigator
Facility:
Name:
Kootenai Health - Coeur d'Alene
Address:
City:
Coeur d'Alene
Zip:
83814
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Clinic Cancer Services - Post Falls
Address:
City:
Post Falls
Zip:
83854
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Kootenai Clinic Cancer Services - Sandpoint
Address:
City:
Sandpoint
Zip:
83864
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Advocate Good Shepherd Hospital
Address:
City:
Barrington
Zip:
60010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-842-4847
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Bloomington
Address:
City:
Bloomington
Zip:
61704
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Canton
Address:
City:
Canton
Zip:
61520
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Carthage
Address:
City:
Carthage
Zip:
62321
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern University
Address:
City:
Chicago
Zip:
60611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1301
Email:
cancer@northwestern.edu
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
University of Illinois
Address:
City:
Chicago
Zip:
60612
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-355-3046
Investigator:
Last name:
Natalie Reizine
Email:
Principal Investigator
Facility:
Name:
University of Chicago Comprehensive Cancer Center
Address:
City:
Chicago
Zip:
60637
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-8222
Email:
cancerclinicaltrials@bsd.uchicago.edu
Investigator:
Last name:
Randy F. Sweis
Email:
Principal Investigator
Facility:
Name:
Advocate Illinois Masonic Medical Center
Address:
City:
Chicago
Zip:
60657
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-296-5360
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
AMG Crystal Lake - Oncology
Address:
City:
Crystal Lake
Zip:
60014
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-929-6129
Email:
advocateresearch@advocate.com
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Cancer Care Specialists of Illinois - Decatur
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Decatur Memorial Hospital
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Kishwaukee
Address:
City:
DeKalb
Zip:
60115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Dixon
Address:
City:
Dixon
Zip:
61021
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
815-285-7800
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Advocate Good Samaritan Hospital
Address:
City:
Downers Grove
Zip:
60515
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-275-1270
Email:
Barbara.barhamand@advocatehealth.com
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Crossroads Cancer Center
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Advocate Sherman Hospital
Address:
City:
Elgin
Zip:
60123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-429-2907
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Eureka
Address:
City:
Eureka
Zip:
61530
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
NorthShore University HealthSystem-Evanston Hospital
Address:
City:
Evanston
Zip:
60201
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-570-2109
Investigator:
Last name:
Nicklas R. Pfanzelter
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Galesburg
Address:
City:
Galesburg
Zip:
61401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Delnor
Address:
City:
Geneva
Zip:
60134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
NorthShore University HealthSystem-Glenbrook Hospital
Address:
City:
Glenview
Zip:
60026
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-570-2109
Investigator:
Last name:
Nicklas R. Pfanzelter
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Glenview Outpatient Center
Address:
City:
Glenview
Zip:
60026
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1102
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Grayslake Outpatient Center
Address:
City:
Grayslake
Zip:
60030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1102
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
NorthShore University HealthSystem-Highland Park Hospital
Address:
City:
Highland Park
Zip:
60035
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-570-2109
Investigator:
Last name:
Nicklas R. Pfanzelter
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Kewanee Clinic
Address:
City:
Kewanee
Zip:
61443
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Lake Forest Hospital
Address:
City:
Lake Forest
Zip:
60045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
cancertrials@northwestern.edu
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
AMG Libertyville - Oncology
Address:
City:
Libertyville
Zip:
60048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-929-6129
Email:
advocateresearch@advocatehealth.com
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Condell Memorial Hospital
Address:
City:
Libertyville
Zip:
60048
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-929-6129
Email:
advocateresearch@advocatehealth.com
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Macomb
Address:
City:
Macomb
Zip:
61455
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
UC Comprehensive Cancer Center at Silver Cross
Address:
City:
New Lenox
Zip:
60451
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-8222
Email:
cancerclinicaltrials@bsd.uchicago.edu
Investigator:
Last name:
Randy F. Sweis
Email:
Principal Investigator
Facility:
Name:
Advocate Christ Medical Center
Address:
City:
Oak Lawn
Zip:
60453-2699
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-323-8622
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Orland Park
Address:
City:
Orland Park
Zip:
60462
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
nctnprogram_rhlccc@northwestern.edu
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
University of Chicago Medicine-Orland Park
Address:
City:
Orland Park
Zip:
60462
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-8222
Email:
cancerclinicaltrials@bsd.uchicago.edu
Investigator:
Last name:
Randy F. Sweis
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Ottawa Clinic
Address:
City:
Ottawa
Zip:
61350
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Advocate Lutheran General Hospital
Address:
City:
Park Ridge
Zip:
60068
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
847-384-3621
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Pekin
Address:
City:
Pekin
Zip:
61554
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Peoria
Address:
City:
Peoria
Zip:
61615
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Peru
Address:
City:
Peru
Zip:
61354
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare-Princeton
Address:
City:
Princeton
Zip:
61356
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Memorial Hospital East
Address:
City:
Shiloh
Zip:
62269
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-747-9912
Email:
dschwab@wustl.edu
Investigator:
Last name:
Melissa A. Reimers
Email:
Principal Investigator
Facility:
Name:
Southern Illinois University School of Medicine
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-545-7929
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Springfield Clinic
Address:
City:
Springfield
Zip:
62702
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-444-7541
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Springfield Memorial Hospital
Address:
City:
Springfield
Zip:
62781
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-528-7541
Email:
pallante.beth@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Warrenville
Address:
City:
Warrenville
Zip:
60555
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
David VanderWeele
Email:
Principal Investigator
Facility:
Name:
Illinois CancerCare - Washington
Address:
City:
Washington
Zip:
61571
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
309-243-3605
Email:
andersonj@illinoiscancercare.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Indiana University/Melvin and Bren Simon Cancer Center
Address:
City:
Indianapolis
Zip:
46202
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
317-278-5632
Email:
iutrials@iu.edu
Investigator:
Last name:
Tareq Salous
Email:
Principal Investigator
Facility:
Name:
Mary Greeley Medical Center
Address:
City:
Ames
Zip:
50010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Ames
Address:
City:
Ames
Zip:
50010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-239-4734
Email:
ksoder@mcfarlandclinic.com
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Ankeny
Address:
City:
Ankeny
Zip:
50023
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-282-2921
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Boone
Address:
City:
Boone
Zip:
50036
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - West Des Moines
Address:
City:
Clive
Zip:
50325
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Iowa Methodist Medical Center
Address:
City:
Des Moines
Zip:
50309
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-6727
Investigator:
Last name:
Seema Harichand-Herdt
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Des Moines
Address:
City:
Des Moines
Zip:
50309
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Seema Harichand-Herdt
Email:
Principal Investigator
Facility:
Name:
Mercy Medical Center - Des Moines
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-358-6613
Email:
cancerresearch@mercydesmoines.org
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
Mission Cancer and Blood - Laurel
Address:
City:
Des Moines
Zip:
50314
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-241-3305
Investigator:
Last name:
Richard L. Deming
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Trinity Cancer Center
Address:
City:
Fort Dodge
Zip:
50501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Jefferson
Address:
City:
Jefferson
Zip:
50129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Marshalltown
Address:
City:
Marshalltown
Zip:
50158
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-956-4132
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
HaysMed
Address:
City:
Hays
Zip:
67601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-623-5774
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center
Address:
City:
Kansas City
Zip:
66160
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
Lawrence Memorial Hospital
Address:
City:
Lawrence
Zip:
66044
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-505-2800
Email:
Stephanie.Norris@LMH.ORG
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
Olathe Health Cancer Center
Address:
City:
Olathe
Zip:
66061
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-355-3943
Email:
atheCCResearch@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center-Overland Park
Address:
City:
Overland Park
Zip:
66210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
Salina Regional Health Center
Address:
City:
Salina
Zip:
67401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-452-7038
Email:
mleepers@srhc.com
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Health System Saint Francis Campus
Address:
City:
Topeka
Zip:
66606
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
785-295-8000
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Hospital-Westwood Cancer Center
Address:
City:
Westwood
Zip:
66205
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kentucky/Markey Cancer Center
Address:
City:
Lexington
Zip:
40536
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
859-257-3379
Investigator:
Last name:
Patrick J. Hensley
Email:
Principal Investigator
Facility:
Name:
Ochsner Medical Center Jefferson
Address:
City:
New Orleans
Zip:
70121
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
504-842-8084
Email:
Elisemarie.curry@ochsner.org
Investigator:
Last name:
Brian T. Halbert
Email:
Principal Investigator
Facility:
Name:
Lafayette Family Cancer Center-EMMC
Address:
City:
Brewer
Zip:
04412
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-987-3005
Investigator:
Last name:
Sarah J. Sinclair
Email:
Principal Investigator
Facility:
Name:
Johns Hopkins University/Sidney Kimmel Cancer Center
Address:
City:
Baltimore
Zip:
21287
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
410-955-8804
Email:
jhcccro@jhmi.edu
Investigator:
Last name:
Jean H. Hoffman-Censits
Email:
Principal Investigator
Facility:
Name:
UPMC Western Maryland
Address:
City:
Cumberland
Zip:
21502
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
240-964-1400
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
Beverly Hospital
Address:
City:
Beverly
Zip:
01915
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
978-922-3000
Phone ext:
2405
Investigator:
Last name:
Brendan Connell
Email:
Principal Investigator
Facility:
Name:
Beth Israel Deaconess Medical Center
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
617-667-9925
Investigator:
Last name:
Daniel E. Fein
Email:
Principal Investigator
Facility:
Name:
Dana-Farber Cancer Institute
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-442-3324
Investigator:
Last name:
Stephanie A. Berg
Email:
Principal Investigator
Facility:
Name:
Steward Saint Elizabeth's Medical Center
Address:
City:
Brighton
Zip:
02135
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
617-789-2903
Investigator:
Last name:
Olga Kozyreva
Email:
Principal Investigator
Facility:
Name:
Lahey Hospital and Medical Center
Address:
City:
Burlington
Zip:
01805
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
781-744-3421
Email:
lhmc-cancer-clinical-trials@lahey.org
Investigator:
Last name:
Brendan Connell
Email:
Principal Investigator
Facility:
Name:
Dana-Farber Cancer Institute at Foxborough
Address:
City:
Foxboro
Zip:
02035
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-338-7425
Investigator:
Last name:
Daniel Roberts
Email:
Principal Investigator
Facility:
Name:
Addison Gilbert Hospital
Address:
City:
Gloucester
Zip:
01930
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
978-283-4000
Phone ext:
559
Investigator:
Last name:
Brendan Connell
Email:
Principal Investigator
Facility:
Name:
Lahey Medical Center-Peabody
Address:
City:
Peabody
Zip:
01960
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
781-744-3421
Email:
lhmc-cancer-clinical-trials@lahey.org
Investigator:
Last name:
Brendan Connell
Email:
Principal Investigator
Facility:
Name:
Dana-Farber/Brigham and Women's Cancer Center at South Shore
Address:
City:
South Weymouth
Zip:
02190
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
781-624-5000
Investigator:
Last name:
Shail Maingi
Email:
Principal Investigator
Facility:
Name:
Winchester Hospital
Address:
City:
Winchester
Zip:
01890
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
888-823-5923
Email:
ctsucontact@westat.com
Investigator:
Last name:
Brendan Connell
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Address:
City:
Ann Arbor
Zip:
48106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
University of Michigan - Brighton Center for Specialty Care
Address:
City:
Brighton
Zip:
48116
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-865-1125
Investigator:
Last name:
Irene Tsung
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
OSF Saint Francis Hospital and Medical Group
Address:
City:
Escanaba
Zip:
49829
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Anthony J. Jaslowski
Email:
Principal Investigator
Facility:
Name:
Genesee Cancer and Blood Disease Treatment Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Genesee Hematology Oncology PC
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Genesys Hurley Cancer Institute
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Hurley Medical Center
Address:
City:
Flint
Zip:
48503
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
810-762-8038
Email:
wstrong@ghci.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
University of Michigan Health - Sparrow Lansing
Address:
City:
Lansing
Zip:
48912
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
517-364-3712
Email:
harsha.trivedi@umhsparrow.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Mary Mercy Livonia Hospital
Address:
City:
Livonia
Zip:
48154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
MyMichigan Medical Center Saginaw
Address:
City:
Saginaw
Zip:
48601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Oncology Hematology Associates of Saginaw Valley PC
Address:
City:
Saginaw
Zip:
48604
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
989-907-8411
Email:
lori.srebinski@ascension.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
MyMichigan Medical Center Tawas
Address:
City:
Tawas City
Zip:
48764
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Saint Mary's Oncology/Hematology Associates of West Branch
Address:
City:
West Branch
Zip:
48661
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
989-907-8411
Email:
lori.srebinski@ascension.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Address:
City:
Ypsilanti
Zip:
48197
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Sanford Joe Lueken Cancer Center
Address:
City:
Bemidji
Zip:
56601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-333-5000
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Fairview Southdale Hospital
Address:
City:
Edina
Zip:
55435
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
952-993-1517
Email:
mmcorc@healthpartners.com
Investigator:
Last name:
Daniel M. Anderson
Email:
Principal Investigator
Facility:
Name:
University of Mississippi Medical Center
Address:
City:
Jackson
Zip:
39216
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
601-815-6700
Investigator:
Last name:
John C. Henegan
Email:
Principal Investigator
Facility:
Name:
Saint Francis Medical Center
Address:
City:
Cape Girardeau
Zip:
63703
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
573-334-2230
Email:
sfmc@sfmc.net
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
MU Health - University Hospital/Ellis Fischel Cancer Center
Address:
City:
Columbia
Zip:
65212
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
573-882-7440
Investigator:
Last name:
Kushal Naha
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at West County Hospital
Address:
City:
Creve Coeur
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Melissa A. Reimers
Email:
Principal Investigator
Facility:
Name:
Parkland Health Center - Farmington
Address:
City:
Farmington
Zip:
63640
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-996-5569
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
University Health Truman Medical Center
Address:
City:
Kansas City
Zip:
64108
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
816-404-4375
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center - North
Address:
City:
Kansas City
Zip:
64154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center - Lee's Summit
Address:
City:
Lee's Summit
Zip:
64064
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
University of Kansas Cancer Center at North Kansas City Hospital
Address:
City:
North Kansas City
Zip:
64116
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
913-588-3671
Email:
KUCC_Navigation@kumc.edu
Investigator:
Last name:
Saqib Abbasi
Email:
Principal Investigator
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Melissa A. Reimers
Email:
Principal Investigator
Facility:
Name:
Veteran's Affairs Medical Center - Saint Louis
Address:
City:
Saint Louis
Zip:
63125
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-9171
Email:
protocols@AllianceNCTN.org
Investigator:
Last name:
Eric M. Knoche
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center-South County
Address:
City:
Saint Louis
Zip:
63129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Melissa A. Reimers
Email:
Principal Investigator
Facility:
Name:
Missouri Baptist Medical Center
Address:
City:
Saint Louis
Zip:
63131
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-996-5569
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Christian Hospital
Address:
City:
Saint Louis
Zip:
63136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Melissa A. Reimers
Email:
Principal Investigator
Facility:
Name:
Mercy Hospital Saint Louis
Address:
City:
Saint Louis
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-251-7066
Investigator:
Last name:
Jay W. Carlson
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Saint Peters Hospital
Address:
City:
Saint Peters
Zip:
63376
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Melissa A. Reimers
Email:
Principal Investigator
Facility:
Name:
Sainte Genevieve County Memorial Hospital
Address:
City:
Sainte Genevieve
Zip:
63670
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-996-5569
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Missouri Baptist Sullivan Hospital
Address:
City:
Sullivan
Zip:
63080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-996-5569
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
BJC Outpatient Center at Sunset Hills
Address:
City:
Sunset Hills
Zip:
63127
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-996-5569
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Billings Clinic Cancer Center
Address:
City:
Billings
Zip:
59101
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-996-2663
Email:
research@billingsclinic.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Bozeman Health Deaconess Hospital
Address:
City:
Bozeman
Zip:
59715
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Benefis Sletten Cancer Institute
Address:
City:
Great Falls
Zip:
59405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Logan Health Medical Center
Address:
City:
Kalispell
Zip:
59901
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Community Medical Center
Address:
City:
Missoula
Zip:
59804
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Nebraska Medicine-Bellevue
Address:
City:
Bellevue
Zip:
68123
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Harshraj Leuva
Email:
Principal Investigator
Facility:
Name:
Nebraska Medicine-Village Pointe
Address:
City:
Omaha
Zip:
68118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-5600
Investigator:
Last name:
Harshraj Leuva
Email:
Principal Investigator
Facility:
Name:
University of Nebraska Medical Center
Address:
City:
Omaha
Zip:
68198
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
402-559-6941
Email:
unmcrsa@unmc.edu
Investigator:
Last name:
Harshraj Leuva
Email:
Principal Investigator
Facility:
Name:
OptumCare Cancer Care at Seven Hills
Address:
City:
Henderson
Zip:
89052
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
John A. Ellerton
Email:
Principal Investigator
Facility:
Name:
OptumCare Cancer Care at Charleston
Address:
City:
Las Vegas
Zip:
89102
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
John A. Ellerton
Email:
Principal Investigator
Facility:
Name:
OptumCare Cancer Care at Fort Apache
Address:
City:
Las Vegas
Zip:
89148
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
702-384-0013
Email:
research@sncrf.org
Investigator:
Last name:
John A. Ellerton
Email:
Principal Investigator
Facility:
Name:
New Hampshire Oncology Hematology PA-Concord
Address:
City:
Concord
Zip:
03301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
603-224-2556
Investigator:
Last name:
Douglas J. Weckstein
Email:
Principal Investigator
Facility:
Name:
Solinsky Center for Cancer Care
Address:
City:
Manchester
Zip:
03103
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-339-6484
Investigator:
Last name:
Douglas J. Weckstein
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Basking Ridge
Address:
City:
Basking Ridge
Zip:
07920
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
Hackensack University Medical Center
Address:
City:
Hackensack
Zip:
07601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
551-996-2897
Investigator:
Last name:
Robert S. Alter
Email:
Principal Investigator
Facility:
Name:
Monmouth Medical Center Southern Campus
Address:
City:
Lakewood
Zip:
08701
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-923-6564
Email:
mary.danish@rwjbh.org
Investigator:
Last name:
Biren Saraiya
Email:
Principal Investigator
Facility:
Name:
Monmouth Medical Center
Address:
City:
Long Branch
Zip:
07740
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-923-6564
Email:
mary.danish@rwjbh.org
Investigator:
Last name:
Biren Saraiya
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Monmouth
Address:
City:
Middletown
Zip:
07748
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Bergen
Address:
City:
Montvale
Zip:
07645
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
Rutgers Cancer Institute of New Jersey
Address:
City:
New Brunswick
Zip:
08903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-235-7356
Investigator:
Last name:
Biren Saraiya
Email:
Principal Investigator
Facility:
Name:
Community Medical Center
Address:
City:
Toms River
Zip:
08755
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
732-557-8294
Email:
Lennette.Gonzales@rwjbh.org
Investigator:
Last name:
Biren Saraiya
Email:
Principal Investigator
Facility:
Name:
University of New Mexico Cancer Center
Address:
City:
Albuquerque
Zip:
87106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
505-925-0348
Email:
HSC-ClinicalTrialInfo@salud.unm.edu
Investigator:
Last name:
Neda Hashemi Sadraei
Email:
Principal Investigator
Facility:
Name:
Presbyterian Kaseman Hospital
Address:
City:
Albuquerque
Zip:
87110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
505-559-6113
Email:
WBurman@phs.org
Investigator:
Last name:
Neda Hashemi Sadraei
Email:
Principal Investigator
Facility:
Name:
Roswell Park Cancer Institute
Address:
City:
Buffalo
Zip:
14263
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-767-9355
Email:
askroswell@roswellpark.org
Investigator:
Last name:
Dharmesh Gopalakrishnan
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Commack
Address:
City:
Commack
Zip:
11725
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
Glens Falls Hospital
Address:
City:
Glens Falls
Zip:
12801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
518-926-6700
Investigator:
Last name:
Steven Ades
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Westchester
Address:
City:
Harrison
Zip:
10604
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
NYU Langone Hospital - Long Island
Address:
City:
Mineola
Zip:
11501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-263-4432
Email:
cancertrials@nyulangone.org
Investigator:
Last name:
Scot A. Niglio
Email:
Principal Investigator
Facility:
Name:
Mount Sinai Chelsea
Address:
City:
New York
Zip:
10011
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-824-7309
Email:
CCTO@mssm.edu
Investigator:
Last name:
Matthew D. Galsky
Email:
Principal Investigator
Facility:
Name:
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Address:
City:
New York
Zip:
10016
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CancerTrials@nyulangone.org
Investigator:
Last name:
Scot A. Niglio
Email:
Principal Investigator
Facility:
Name:
Mount Sinai Hospital
Address:
City:
New York
Zip:
10029
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-824-7309
Email:
CCTO@mssm.edu
Investigator:
Last name:
Matthew D. Galsky
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Cancer Center
Address:
City:
New York
Zip:
10065
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
University of Rochester
Address:
City:
Rochester
Zip:
14642
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
585-275-5830
Investigator:
Last name:
Paul M. Barr
Email:
Principal Investigator
Facility:
Name:
Memorial Sloan Kettering Nassau
Address:
City:
Uniondale
Zip:
11553
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
212-639-7592
Investigator:
Last name:
David H. Aggen
Email:
Principal Investigator
Facility:
Name:
UNC Lineberger Comprehensive Cancer Center
Address:
City:
Chapel Hill
Zip:
27599
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-668-0683
Email:
cancerclinicaltrials@med.unc.edu
Investigator:
Last name:
Matthew I. Milowsky
Email:
Principal Investigator
Facility:
Name:
Sanford Bismarck Medical Center
Address:
City:
Bismarck
Zip:
58501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Broadway Medical Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-323-5760
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford Roger Maris Cancer Center
Address:
City:
Fargo
Zip:
58122
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
701-234-6161
Email:
OncologyClinicalTrialsFargo@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Ohio State University Comprehensive Cancer Center
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-293-5066
Email:
Jamesline@osumc.edu
Investigator:
Last name:
Lingbin Meng
Email:
Principal Investigator
Facility:
Name:
ProMedica Flower Hospital
Address:
City:
Sylvania
Zip:
43560
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
419-824-1842
Email:
PCIOncResearch@promedica.org
Investigator:
Last name:
Jeffrey H. Muler
Email:
Principal Investigator
Facility:
Name:
Cancer Centers of Southwest Oklahoma Research
Address:
City:
Lawton
Zip:
73505
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-231-4440
Investigator:
Last name:
Adanma Anji Ayanambakkam Attanathi
Email:
Principal Investigator
Facility:
Name:
University of Oklahoma Health Sciences Center
Address:
City:
Oklahoma City
Zip:
73104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
405-271-8777
Email:
ou-clinical-trials@ouhsc.edu
Investigator:
Last name:
Adanma Anji Ayanambakkam Attanathi
Email:
Principal Investigator
Facility:
Name:
Oklahoma Cancer Specialists and Research Institute-Tulsa
Address:
City:
Tulsa
Zip:
74146
Country:
United States
Status:
Suspended
Facility:
Name:
Providence Willamette Falls Medical Center
Address:
City:
Oregon City
Zip:
97045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Providence Portland Medical Center
Address:
City:
Portland
Zip:
97213
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Providence Saint Vincent Medical Center
Address:
City:
Portland
Zip:
97225
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-215-2614
Email:
CanRsrchStudies@providence.org
Investigator:
Last name:
Alison K. Conlin
Email:
Principal Investigator
Facility:
Name:
Oregon Health and Science University
Address:
City:
Portland
Zip:
97239
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
503-494-1080
Email:
trials@ohsu.edu
Investigator:
Last name:
Ronald Ng
Email:
Principal Investigator
Facility:
Name:
Lehigh Valley Hospital-Cedar Crest
Address:
City:
Allentown
Zip:
18103
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
610-402-9543
Email:
Morgan_M.Horton@lvhn.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
UPMC Altoona
Address:
City:
Altoona
Zip:
16601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
773-702-9171
Email:
protocols@AllianceNCTN.org
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
Lehigh Valley Hospital - Muhlenberg
Address:
City:
Bethlehem
Zip:
18017
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
610-402-9543
Email:
Morgan_M.Horton@lvhn.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
Pocono Medical Center
Address:
City:
East Stroudsburg
Zip:
18301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
610-402-9543
Email:
Morgan_M.Horton@lvhn.org
Investigator:
Last name:
Elie G. Dib
Email:
Principal Investigator
Facility:
Name:
UPMC Hillman Cancer Center Erie
Address:
City:
Erie
Zip:
16505
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-389-5208
Email:
haneydl@upmc.edu
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
UPMC Cancer Centers - Arnold Palmer Pavilion
Address:
City:
Greensburg
Zip:
15601
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
724-838-1900
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
UPMC Pinnacle Cancer Center/Community Osteopathic Campus
Address:
City:
Harrisburg
Zip:
17109
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
717-724-6765
Email:
klitchfield@PINNACLEHEALTH.org
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
Address:
City:
Mechanicsburg
Zip:
17050
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-389-5208
Email:
haneydl@upmc.edu
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
UPMC Hillman Cancer Center - Monroeville
Address:
City:
Monroeville
Zip:
15146
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-389-5208
Email:
haneydl@upmc.edu
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
University of Pennsylvania/Abramson Cancer Center
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
855-216-0098
Email:
PennCancerTrials@careboxhealth.com
Investigator:
Last name:
Ronac Mamtani
Email:
Principal Investigator
Facility:
Name:
Thomas Jefferson University Hospital
Address:
City:
Philadelphia
Zip:
19107
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
215-600-9151
Email:
ONCTrialNow@jefferson.edu
Investigator:
Last name:
Patrick Mille
Email:
Principal Investigator
Facility:
Name:
UPMC-Saint Margaret
Address:
City:
Pittsburgh
Zip:
15215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-784-4900
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
University of Pittsburgh Cancer Institute (UPCI)
Address:
City:
Pittsburgh
Zip:
15232
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-647-8073
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
UPMC-Passavant Hospital
Address:
City:
Pittsburgh
Zip:
15237
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-367-6454
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
UPMC-Saint Clair Hospital Cancer Center
Address:
City:
Pittsburgh
Zip:
15243
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-502-3920
Investigator:
Last name:
Priyanka V. Chablani
Email:
Principal Investigator
Facility:
Name:
Smilow Cancer Hospital Care Center - Westerly
Address:
City:
Westerly
Zip:
02891
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
203-785-5702
Email:
canceranswers@yale.edu
Investigator:
Last name:
Joseph W. Kim
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Spartanburg
Address:
City:
Boiling Springs
Zip:
29316
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Easley
Address:
City:
Easley
Zip:
29640
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-522-2066
Email:
Kim.Williams3@prismahealth.org
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Butternut
Address:
City:
Greenville
Zip:
29605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Faris
Address:
City:
Greenville
Zip:
29605
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Eastside
Address:
City:
Greenville
Zip:
29615
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Greer
Address:
City:
Greer
Zip:
29650
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Prisma Health Cancer Institute - Seneca
Address:
City:
Seneca
Zip:
29672
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
864-241-6251
Investigator:
Last name:
Ki Y. Chung
Email:
Principal Investigator
Facility:
Name:
Sanford Cancer Center Oncology Clinic
Address:
City:
Sioux Falls
Zip:
57104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicTrialsSF@sanfordhealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
Sanford USD Medical Center - Sioux Falls
Address:
City:
Sioux Falls
Zip:
57117-5134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
605-312-3320
Email:
OncologyClinicalTrialsSF@SanfordHealth.org
Investigator:
Last name:
Daniel Almquist
Email:
Principal Investigator
Facility:
Name:
The West Clinic - Wolf River
Address:
City:
Germantown
Zip:
38138
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
901-683-0055
Email:
afletcher@westclinic.com
Investigator:
Last name:
Bradley G. Somer
Email:
Principal Investigator
Facility:
Name:
UT Southwestern Simmons Cancer Center - RedBird
Address:
City:
Dallas
Zip:
75237
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@utsouthwestern.edu
Investigator:
Last name:
Tian Zhang
Email:
Principal Investigator
Facility:
Name:
UT Southwestern/Simmons Cancer Center-Dallas
Address:
City:
Dallas
Zip:
75390
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@UTSouthwestern.edu
Investigator:
Last name:
Tian Zhang
Email:
Principal Investigator
Facility:
Name:
UT Southwestern/Simmons Cancer Center-Fort Worth
Address:
City:
Fort Worth
Zip:
76104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
214-648-7097
Email:
canceranswerline@UTSouthwestern.edu
Investigator:
Last name:
Tian Zhang
Email:
Principal Investigator
Facility:
Name:
UT Southwestern Clinical Center at Richardson/Plano
Address:
City:
Richardson
Zip:
75080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
972-669-7044
Email:
Suzanne.cole@utsouthwestern.edu
Investigator:
Last name:
Tian Zhang
Email:
Principal Investigator
Facility:
Name:
University of Vermont Medical Center
Address:
City:
Burlington
Zip:
05401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
802-656-4101
Email:
rpo@uvm.edu
Investigator:
Last name:
Steven Ades
Email:
Principal Investigator
Facility:
Name:
University of Vermont and State Agricultural College
Address:
City:
Burlington
Zip:
05405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
802-656-8990
Email:
rpo@uvm.edu
Investigator:
Last name:
Steven Ades
Email:
Principal Investigator
Facility:
Name:
University of Virginia Cancer Center
Address:
City:
Charlottesville
Zip:
22908
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
434-243-6303
Email:
uvacancertrials@hscmail.mcc.virginia.edu
Investigator:
Last name:
Paul V. Viscuse
Email:
Principal Investigator
Facility:
Name:
VCU Massey Cancer Center at Stony Point
Address:
City:
Richmond
Zip:
23235
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
ctoclinops@vcu.edu
Investigator:
Last name:
John Melson
Email:
Principal Investigator
Facility:
Name:
Virginia Commonwealth University/Massey Cancer Center
Address:
City:
Richmond
Zip:
23298
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
CTOclinops@vcu.edu
Investigator:
Last name:
John Melson
Email:
Principal Investigator
Facility:
Name:
VCU Community Memorial Health Center
Address:
City:
South Hill
Zip:
23970
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
nemer.elmouallem@vcuhealth.org
Investigator:
Last name:
John Melson
Email:
Principal Investigator
Facility:
Name:
West Virginia University Charleston Division
Address:
City:
Charleston
Zip:
25304
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
304-388-9944
Investigator:
Last name:
Kok Hoe Chan
Email:
Principal Investigator
Facility:
Name:
Aurora Saint Luke's South Shore
Address:
City:
Cudahy
Zip:
53110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Grafton
Address:
City:
Grafton
Zip:
53024
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center Green Bay
Address:
City:
Green Bay
Zip:
54301
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Anthony J. Jaslowski
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center at Saint Mary's
Address:
City:
Green Bay
Zip:
54303
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Anthony J. Jaslowski
Email:
Principal Investigator
Facility:
Name:
Aurora BayCare Medical Center
Address:
City:
Green Bay
Zip:
54311
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
Address:
City:
Madison
Zip:
53718
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-622-8922
Email:
clinicaltrials@cancer.wisc.edu
Investigator:
Last name:
Christos Kyriakopoulos
Email:
Principal Investigator
Facility:
Name:
University of Wisconsin Carbone Cancer Center - University Hospital
Address:
City:
Madison
Zip:
53792
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-622-8922
Email:
clinicaltrials@cancer.wisc.edu
Investigator:
Last name:
Christos Kyriakopoulos
Email:
Principal Investigator
Facility:
Name:
Aurora Bay Area Medical Group-Marinette
Address:
City:
Marinette
Zip:
54143
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Aurora Saint Luke's Medical Center
Address:
City:
Milwaukee
Zip:
53215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Medical College of Wisconsin
Address:
City:
Milwaukee
Zip:
53226
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-805-3666
Investigator:
Last name:
Ariel Nelson
Email:
Principal Investigator
Facility:
Name:
Aurora Sinai Medical Center
Address:
City:
Milwaukee
Zip:
53233
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
ProHealth D N Greenwald Center
Address:
City:
Mukwonago
Zip:
53149
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Email:
research.institute@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
ProHealth Oconomowoc Memorial Hospital
Address:
City:
Oconomowoc
Zip:
53066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-7878
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center at Oconto Falls
Address:
City:
Oconto Falls
Zip:
54154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Anthony J. Jaslowski
Email:
Principal Investigator
Facility:
Name:
Vince Lombardi Cancer Clinic - Oshkosh
Address:
City:
Oshkosh
Zip:
54904
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center at Sheboygan
Address:
City:
Sheboygan
Zip:
53081
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Anthony J. Jaslowski
Email:
Principal Investigator
Facility:
Name:
Vince Lombardi Cancer Clinic-Sheboygan
Address:
City:
Sheboygan
Zip:
53081
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Saint Vincent Hospital Cancer Center at Sturgeon Bay
Address:
City:
Sturgeon Bay
Zip:
54235-1495
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
920-433-8889
Email:
ewd_research_admin@hshs.org
Investigator:
Last name:
Anthony J. Jaslowski
Email:
Principal Investigator
Facility:
Name:
Aurora Medical Center in Summit
Address:
City:
Summit
Zip:
53066
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Vince Lombardi Cancer Clinic-Two Rivers
Address:
City:
Two Rivers
Zip:
54241
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
ProHealth Waukesha Memorial Hospital
Address:
City:
Waukesha
Zip:
53188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-7632
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
UW Cancer Center at ProHealth Care
Address:
City:
Waukesha
Zip:
53188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
262-928-5539
Email:
Chanda.miller@phci.org
Investigator:
Last name:
Timothy R. Wassenaar
Email:
Principal Investigator
Facility:
Name:
Aurora Cancer Care-Milwaukee West
Address:
City:
Wauwatosa
Zip:
53226
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Facility:
Name:
Aurora West Allis Medical Center
Address:
City:
West Allis
Zip:
53227
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
414-302-2304
Email:
ncorp@aurora.org
Investigator:
Last name:
Adam P. Siegel
Email:
Principal Investigator
Start date:
February 2, 2024
Completion date:
April 11, 2026
Lead sponsor:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
National Cancer Institute (NCI)
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05987241
